The top drug regulator at the FDA told staff she plans to question the safety of taking SSRIs in pregnancy and of RSV shots ...

Researchers in China recently published a study in Science Translational Medicine describing a new antibody cocktail for ...

Market normalization reflects maturation, not decline - strategic transition creates opportunities in precision immunization, ...

After winning an initial U.S. nod in July 2023, Beyfortus has gone on to do gangbusters for Sanofi and AZ, growing total sales 9.5% last year for a total haul of 1.78 billion euros (roughly $2.1 ...

Merck & Co. MRK on Thursday shared positive second RSV season findings from the Phase 3 SMART trial. The results from the SMART trial were presented at the RSVVW Conference and will be shared with the ...

AT 12, Malachi should be hanging out with friends and playing football in the park. But unlike most kids his age, the youngster can’t dress or feed himself and needs round-the-clock ...

Merck (MRK) reports positive Phase 3 SMART trial results for ENFLONSIA in high-risk infants/children vs RSV, with consistent safety and dosing—read ...

UPMC Children’s Community Pediatrics reports rsv, flu and viral upper respiratory infections this week. Penn Medicine Lancaster General Health Physicians Roseville Pediatrics is reporting a ...

Cook Government to expand access to free respiratory syncytial virus (RSV) vaccines to older Western Australians in ...

Antibodies harvested from the blood of paediatricians are up to 25 times better at protecting against the common respiratory ...

Constant exposure to diverse diseases is an occupational hazard for all healthcare workers, especially those who work with children. | Constant exposure to diverse diseases is an occupational hazard ...

An interim analysis of safety data showed no increased risk associated with Pfizer’s respiratory syncytial virus vaccine when ...